Brief: Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing
BRIEF-Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing Oct 22 (Reuters) - Lucid Diagnostics Inc LUCD.O:
LUCID DIAGNOSTICS BEGINS RECEIVING MEDICARE REIMBURSEMENT FOR ESOGUARD® AND CLOSES $15 MILLION FINANCING
Source text: ID:nPn89tqVFa
Further company coverage: LUCD.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Lucid Diagnostics
See all newsBrief: Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing
Lucid Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Lucid Diagnostics Inc expected to post a loss of 7 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks
U.S. STOCKS ON THE MOVE- American Airlines, Pot stocks, Paramount Skydance